BioSig Technologies (BSGM) - נכסים מצרפיים של הפעילות העסקית

Biosig Technologies (BSGM) relies on the implementation of high-precision data processing systems for cardiac surgeons, aiming to increase the efficiency of arrhythmia ablation procedures. The company develops unique noise filtration tools that ensure flawless visualization of heart function. However, a weak market position forces the company to lower prices to implement pilot projects. This chart reflects the company's price action based on total assets at 56.52.

By expanding the licensing of IT platforms for cardiac pacing in the US, Biosig Technologies (BSGM) aims to diversify its revenue, while the value of consolidated assets, reverse-calculated via ROA, reflects the company's total resource potential, allowing investors to compare the actual growth of the asset base with operational efficiency and determine the sustainability of current market share pricing relative to the actual volume of controlled capital.